Company intelligence / Profile preview

PragmaClin Research

St. John's, Newfoundland & Labrador, Canadapragmaclin.com ↗

Ownership: Private
Development stage: Preclinical

Overview

PragmaClin has developed PRIMS®, a digital assessment tool that uses 3D depth cameras and machine learning to provide objective, remote or in-clinic neurological assessments for people with Parkinson’s Disease. The system adheres to MDS-UPDRS guidelines and is designed to improve accuracy and frequency of monitoring compared to traditional subjective methods. Clinical validation is ongoing with strong early adoption in Canada

Therapeutic areas: Neurology
Modalities: DeviceNon-pharmacological therapyDigital health platform
Industry: Digital Health Medical Devices

Beyond the preview

Go deeper on PragmaClin Research.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PragmaClin Research.

Explore the full profile